To include your compound in the COVID-19 Resource Center, submit it here.

Monoclonal antibody in RA: Phase II

In a dose-escalating Phase II trial, 1 of 3 patients

Read the full 109 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE